First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 287.02 USD -0.69% Market Closed
Updated: Jun 9, 2024

Bio Rad Laboratories Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bio Rad Laboratories Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Bio Rad Laboratories Inc
NYSE:BIO
Cash & Cash Equivalents
$433.3m
CAGR 3-Years
-14%
CAGR 5-Years
-1%
CAGR 10-Years
2%
Thermo Fisher Scientific Inc
NYSE:TMO
Cash & Cash Equivalents
$5.5B
CAGR 3-Years
-1%
CAGR 5-Years
38%
CAGR 10-Years
14%
Danaher Corp
NYSE:DHR
Cash & Cash Equivalents
$7B
CAGR 3-Years
4%
CAGR 5-Years
12%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Cash & Cash Equivalents
$70.2m
CAGR 3-Years
-13%
CAGR 5-Years
-11%
CAGR 10-Years
-5%
Agilent Technologies Inc
NYSE:A
Cash & Cash Equivalents
$1.7B
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
IQVIA Holdings Inc
NYSE:IQV
Cash & Cash Equivalents
$1.4B
CAGR 3-Years
-14%
CAGR 5-Years
9%
CAGR 10-Years
7%

See Also

What is Bio Rad Laboratories Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
433.3m USD

Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Cash & Cash Equivalents amounts to 433.3m USD.

What is Bio Rad Laboratories Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
2%

Over the last year, the Cash & Cash Equivalents growth was -7%. The average annual Cash & Cash Equivalents growth rates for Bio Rad Laboratories Inc have been -14% over the past three years , -1% over the past five years , and 2% over the past ten years .